1) Laumann E, Paik A, Rosen R. Sexual dysfunction in the United States: prevalence and predictors [published erratum appears in JAMA 1999;281:1174]. JAMA 1999; 281: 537-544[ISI][Medline]. 2) Berman J, Berman L, Goldstein I. Female sexual dysfunction: incidence, pathophysiology, evaluation, and treatment options. Urology 1999; 54: 385-391[ISI][Medline].  3)   Cooke R. There's gold in them there pills. Observer 2002 October 27.  4)  Bancroft J. The medicalization of female sexual dysfunction: the need for caution. Arch Sex Behavr 2002; 31: 451-455.  5)  Segraves R, ed. Historical and international context of nosology of female sexual disorders. J Sex Marital Therapy 2001; 27(2): 81-245[ISI].  6)  Tiefer L. The medicalization of sexuality: conceptual, normative, and professional issues. Annu Rev Sex Res 1996; 7: 252-282.  7)  Tiefer L. Sexology and the pharmaceutical industry: the threat of co-optation. J Sex Res 2000; 37: 273-283[ISI].  8) http://www.nytimes.com/2004/10/14/business/14merck.html?ex=1101877200&en=e6dc1bc5f48f8d6b&ei=5070